MiR-141 and mir-152 seemed to discriminate a rare, but highly significant sub-group of PCa patients, i.e. , individuals with a higher than 90% probability of recurrence after prostatectomy.
← all excerpts
Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer.
1
—
—